Manufacturing

Articles

FDA Recommends Changes for 2006-2007 Flu Vaccine

Baxter Wins Contract to Develop Cell-Based H5N1 Vaccine

Cambrex (East Rutherford, NJ) to produce Geron (Menlo Park, CA) telomerase anti-cancer vaccine. Generex (Toronto, ON.) files IND for synthetic vaccine to stimulate cell-mediated immunity to avian influenza. Dow Agrosciences (Indianapolis, IN) wins USDA approval for veterinary vaccine, the first manufactured via plant cell culture. G-8 nations pledge billons for vaccine production.

Vaccine News: Telomerase vs. Cancer; Synthetic Approach to Avian Flu; First Plant-Made Vaccine

Merck wins approval for rotavirus vaccine as Sanofi ships investigational H5N1 vaccine to NIH and CDC explores new flue diagnostics and novel vaccine-production technology.

Antivirus Wrap-Up: Vaccines and More Fight Avian Influenza, Rotavirus

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Dow AgroSciences Receives Regulatory Approval for Plant-Made Vaccine

Cell-Grown Vaccine Protects Against Avian Flu Virus

Sanofi Pasteur and BD Team Up to Produce Microneedle Vaccines

SEC Loosens Revenue-Recognition Rules for Vaccine Stockpile Participants

NIAID Boosts Vaccine Innovation but Draws Controversy

Adjuvant for HPV Vaccine Enhances Immune Response Levels

Manufacturing, Biologic Drugs